U.S. Patent No. 10,405,560 B2

Cannabis IP patent

  U.S. Patent No. 10,405,560 B2 (‘560) issued on September 10, 2019, for “Method for Making Coffee Products Containing Cannabis Ingredients.”  It was issued to inventor Christopher Bhairam of Garden City, New York.  The applicant/assignee is Blacklist Holdings, Inc. of Tacoma, Washington.  The specification discloses several embodiments of making coffee with different combinations of cannabinoid …

Continue Reading

U.S. Patent No. PP30,872 P2

patent plantIP

U.S. Patent No. PP30,872 P2 (‘872) issued on September 3, 2019, for “Phalaenopsis Orchid Plant Named ‘Phalgaqxyk’.”  It was issued to inventor Martinus Nicolaas Gerardus Van Swieten of Utrecht, Netherlands.  The applicant/assignee is Anthura, B.V., of Bleiswijk, Netherlands.  This patent is a plant patent under 35 U.S.C. §161, which protects new and distinct cultivars of …

Continue Reading

SCOTUS Watch: SCOTUS Decides Against Wading into 101 Quagmire

101 11th amendment patent patent eligible subject matter scotus watch sovereign immunity

On January 13, 2020, the U.S. Supreme Court denied petitions for writs of certiorari in four cases dealing with patent subject matter-eligibility: HP Inc. v. Berkheimer, Hikma Pharms., Inc. v. Vanda Pharms., Inc., Garmin USA, Inc. v. Cellspin Soft, Inc., and Athena Diagnostics, Inc. v. Mayo Collaborative Servs., which was discussed earlier on this blog.  …

Continue Reading

SCOTUS Watch: Patent Eligibility Showdown Looming Before Supreme Court

101 patent patent eligible subject matter scotus watch

On January 10, 2020, the U.S. Supreme Court will discuss at its first conference meeting whether or not to take up one to four cases dealing with patent eligibility under 35 U.S.C. §101.  Patent eligibility has been a contentious source of patent application rejections or invalidations during post-grant litigation.  Medical diagnostics and software have been …

Continue Reading